Related Experiment Video
Updated: Sep 26, 2025
06:43
Standardized Processing for Formalin-Fixed, Paraffin-Embedded Cell Pellet Immunohistochemistry Controls
Published on: July 27, 2022
8.3K
Quality Issues in Diagnostic Immunohistochemistry in Breast Pathology
Raza S Hoda1, Edi Brogi2, Hannah Y Wen3
1Robert J Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Summary
Immunohistochemistry in breast pathology aids diagnosis but sole reliance can cause errors. Careful histopathological evaluation is crucial to avoid misdiagnosis and ensure accurate patient care.
Area of Science:
- Surgical Pathology
- Oncology
- Histopathology
Background:
- Immunohistochemistry (IHC) is integral to surgical pathology, particularly in breast pathology.
- IHC provides prognostic and predictive data, aiding in diagnosis, assessment of stromal invasion, and mammary origin determination.
Purpose of the Study:
- To review common pitfalls of immunohistochemistry in breast pathology.
- To emphasize the importance of integrating IHC with careful histopathological evaluation.
Main Methods:
- Review of existing literature and clinical practice guidelines.
- Analysis of diagnostic challenges in breast pathology where IHC is utilized.
Main Results:
- Sole reliance on immunohistochemistry can lead to misdiagnosis in breast pathology.
- Specific diagnostic scenarios highlight the limitations of IHC without comprehensive histopathological assessment.
Conclusions:
- Immunohistochemistry is a valuable tool but not infallible in breast pathology.
- Combining IHC with thorough histopathological evaluation is essential for accurate diagnosis and patient management.
